The risk of developing RDS was significantly increased among newborns born to mothers with confirmed COVID-19 infection during pregnancy.
Surfactant therapy has become a routine for neonatal respiratory care and already proved to reduce morbidity and mortality in neonatal respiratory distress syndrome. The surfactant replacement has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback